Getagraph.com logo
S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(0.12%) $82.73
Gas
(1.03%) $2.05
Gold
(-0.48%) $2 346.50
Silver
(-0.94%) $27.40
Platinum
(-0.26%) $959.00
USD/EUR
(-0.25%) $0.932
USD/NOK
(-0.37%) $10.98
USD/GBP
(-0.56%) $0.796
USD/RUB
(1.56%) $93.31

Sanntidsoppdatering for Suven Life Sciences [SUVEN.NS]

Børs: NSE Sektor: Healthcare Industri: Drug Manufacturers—Specialty & Generic
Sist oppdatert29 apr 2024 @ 12:00
25% discount on Stockinvest.us - Use code: Podcast

-0.09% INR 111.35

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 12:00):

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally...

Stats
Dagens volum 147 183
Gjennomsnittsvolum 254 289
Markedsverdi 24.28B
EPS INR0 ( 2024-01-29 )
Neste inntjeningsdato ( INR0 ) 2024-05-06
Last Dividend INR1.382 ( 2019-02-14 )
Next Dividend INR0 ( N/A )
P/E -23.34
ATR14 INR0.171 (0.15%)

Volum Korrelasjon

Lang: 0.20 (neutral)
Kort: 0.27 (neutral)
Signal:(49.981) Neutral

Suven Life Sciences Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Suven Life Sciences Korrelasjon - Valuta/Råvare

The country flag 0.47
( neutral )
The country flag 0.40
( neutral )
The country flag 0.00
( neutral )
The country flag -0.16
( neutral )
The country flag -0.33
( neutral )
The country flag -0.40
( neutral )

Suven Life Sciences Økonomi

Annual 2022
Omsetning: INR135.39M
Bruttogevinst: INR129.74M (95.82 %)
EPS: INR-6.63
FY 2022
Omsetning: INR135.39M
Bruttogevinst: INR129.74M (95.82 %)
EPS: INR-6.63
FY 2022
Omsetning: INR118.44M
Bruttogevinst: INR118.44M (100.00 %)
EPS: INR-8.86
FY 2021
Omsetning: INR134.78M
Bruttogevinst: INR134.78M (100.00 %)
EPS: INR-5.67

Financial Reports:

No articles found.

Suven Life Sciences Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Suven Life Sciences Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.880 - No dividend growth expected in the near future
Information
First Dividend INR0.230 2004-09-10
Last Dividend INR1.382 2019-02-14
Next Dividend INR0 N/A
Payout Date 2019-02-25
Next Payout Date N/A
# dividends 16 --
Total Paid Out INR8.02 --
Avg. Dividend % Per Year 0.00% --
Score 0.66 --
Div. Sustainability Score 0
Div.Growth Potential Score 1.880
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-11-12)
INR0 Estimate 0.00 %
Dividend Stability
0.04 Very Bad
Dividend Score
0.66
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR1.382 0.73%
2019 INR1.382 0.60%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LAURUSLABS.NS Dividend Knight 2023-05-10 Semi-Annually 8 0.35%
FOSECOIND.NS Dividend Knight 2023-05-17 Annually 22 0.68%
APOLLO.NS Dividend Junior 2023-09-22 Annually 7 0.79%
TCI.NS Dividend Junior 2023-07-25 Semi-Annually 23 0.70%
OBEROIRLTY.NS Dividend Junior 2023-06-21 Sporadic 14 0.19%
INFOBEAN.NS Dividend Junior 2023-07-21 Annually 7 0.37%
CONCOR.NS Dividend Knight 2023-09-18 Semi-Annually 23 0.89%
SCI.NS Dividend Junior 2023-09-01 Sporadic 22 0.25%
MALLCOM.NS Dividend Junior 2023-09-04 Annually 3 0.20%
GOKEX.NS Dividend Junior 2023-09-13 Sporadic 20 0.07%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-8.911.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM-0.2981.500-4.42-6.63[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM-652.211.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM0.6112.009.8010.00[0 - 30]
freeCashFlowPerShareTTM0.6112.009.6910.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM-1.6861.000-10.00-10.00[0.2 - 0.8]
operatingProfitMarginTTM-9.991.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-4.38

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-22.801.000-2.400[1 - 100]
returnOnEquityTTM-0.2982.50-2.84-6.63[0.1 - 1.5]
freeCashFlowPerShareTTM0.6112.009.8010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.6112.009.8010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.3311.500-1.1300[0.5 - 2]
operatingCashFlowSalesRatioTTM1.1191.00010.000[0.1 - 0.5]
Total Score1.880

Suven Life Sciences

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of Alzheimer's disease and neuropsychiatric symptoms; SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and SUVN-911, a novel, potent, and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing SUVN-D4010, a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders and schizophrenia; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.